Chemical Compound

Demethoxybuprenorphine

CAS Registry Number 89663-73-0
Demethoxybuprenorphine chemical structure
Primary Record

Demethoxybuprenorphine

In stock
8,227 g
Purity
98.1 %
CAS
89663-73-0

Compound Identifiers & Properties

CAS
89663-73-0
PubChem CID
93488712
SMILES
CC1([C@H]2C[C@@]34CC[C@@]2([C@H]5[C@@]36CCN([C@@H]4CC7=C6C(=C(C=C7)O)O5)CC8CC8)OC1(C)C)C
Canonical SMILES
CC1(C)O[C@]23CC[C@@]4(C[C@@H]2C1(C)C)[C@H]1Cc2ccc(O)c5c2[C@@]4(CCN1CC1CC1)[C@H]3O5

Names & Synonyms

  • Demethoxybuprenorphine
  • Buprenorphine Furan
  • Buprenorphine Furanyl Impurity
  • Buprenorphine Impurity I
  • RefChem:131718
  • Z7N3HL2G9P
  • SCHEMBL19120525
  • ZINC38800261
  • IB19360
  • BUPRENORPHINE IMPURITY I [EP IMPURITY]
  • J1.073.142I
  • (4bS,8R,8aS,9aR,12aR,12bR)-7-(Cyclopro
  • 89663-73-0
  • 3-(2-Butylphenyl)-5-phenyl-1H-1,2,4-triazole
  • 5-(2-butylphenyl)-3-phenyl-1h-1,2,4-triazole
  • Buprenorphine Furanyl Impurity (Buprenorphine Impurity I)
  • BUPRENORPHINE HYDROCHLORIDE IMPURITY I [EP IMPURITY]
  • 6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-alpha-methyl-, (5alpha,7alpha(S))-
  • 91423-89-1
  • 17-(Cyclopropylmethyl)-4'',4'',5'',5''-tetramethyl-4'',5''dihydro-(7betaH)-6alpha,14-ethano-(5betaH)-difurano[2',3',4',5':4,12,13,5;2'',3'':6,7]-14alpha-morphinan-3-ol
  • 8a,12a-Ethano-4,8-methano-12bH-benzofuro(3,2-e)furo(2,3-g)isoquinolin-1-ol, 7-(cyclopropylmethyl)-5,6,7,8,9,9a,10,11-octahydro-10,10,11,11-tetramethyl-, (8R-(4bS*,8alpha,8aalpha,9abeta,12aalpha,12bbeta))-
  • Buprenorphine Furanyl Impurity (Buprenorphine Impurity I) (1 mg/ml in Acetonitrile)
  • Buprenorphine Furanyl Impurity (Buprenorphine Impurity I) (1.0mg/ml in Acetonitrile)
  • (1R,2R,10S,14R,15S,17R)-13-(cyclopropylmethyl)-18,18,19,19-tetramethyl-3,20-dioxa-13-azaheptacyclo[13.5.2.18,14.01,17.02,10.04,9.010,15]tricosa-4(9),5,7-trien-5-ol
  • (2S,6R,14R)-5-(cyclopropylmethyl)-17,17,18,18-tetramethyl-13,16-dioxa-5-azaheptacyclo[13.5.2.12,8.01,6.02,14.015,19.012,23]tricosa-8(23),9,11-trien-11-ol
  • (4bS,8R,8aS,9aR,12aR,12bR)-7-(Cyclopropylmethyl)-5,6,7,8,9,9a,10,11-octahydro-10,10,11,11-tetramethyl-8a,12a-ethano-4,8-methano-12bH-benzofuro[3,2-e]furo[2,3-g]isoquinolin-1-ol
  • (6R,14R,19R)-5-(cyclopropylmethyl)-17,17,18,18-tetramethyl-13,16-dioxa-5-azaheptacyclo[13.5.2.12,8.01,6.02,14.015,19.012,23]tricosa-8(23),9,11-trien-11-ol
  • [8R-(4bS*,8a,8a-a,9a-b,12a-a,12b-b)]-7-(Cyclopropylmethyl)-5,6,7,8,9,9a,10,11-octahydro-10,10,11,11-tetrame thyl-8a,12a-ethano-4,8-methano-12bH-benzofuro[3,2-e]furo[2,3-g]isoquinolin-1-ol
  • 3-Hydroxy-17-(cyclopropylmethyl)-20,20,21,21-tetramethyl-4,5alpha-epoxy-6beta,7alpha-(epoxyethano)-6,14alpha-ethanomorphinan
  • 8a,12a-Ethano-4,8-methano-12bH-benzofuro[3,2-e]furo[2,3-g]isoquinolin-1-ol, 7-(cyclopropylmethyl)-5,6,7,8,9,9a,10,11-octahydro-10,10,11,11-tetramethyl-, (4bS,8R,8aS,9aR,12aR,12bR)- (9CI); Buprenorphine Imp. I (EP)
  • 8a,12a-Ethano-4,8-methano-12bH-benzofuro[3,2-e]furo[2,3-g]isoquinolin-1-ol, 7-(cyclopropylmethyl)-5,6,7,8,9,9a,10,11-octahydro-10,10,11,11-tetramethyl-, [8R-(4bS*,8alpha,8aalpha,9abeta,12aalpha,12bbeta)]-